Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.
Bastholt L, Dalmark M, Gjedde SB, Pfeiffer P, Pedersen D, Sandberg E, Kjaer M, Mouridsen HT, Rose C, Nielsen OS, Jakobsen P, Bentzen SM. Bastholt L, et al. Among authors: mouridsen ht. J Clin Oncol. 1996 Apr;14(4):1146-55. doi: 10.1200/JCO.1996.14.4.1146. J Clin Oncol. 1996. PMID: 8648369 Clinical Trial.
Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer--a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group (DBCG).
Andersson M, Madsen EL, Overgaard M, Rose C, Dombernowsky P, Mouridsen HT. Andersson M, et al. Among authors: mouridsen ht. Eur J Cancer. 1999 Jan;35(1):39-46. doi: 10.1016/s0959-8049(98)00354-2. Eur J Cancer. 1999. PMID: 10211086 Clinical Trial.
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
Rose C, Kamby C, Mouridsen HT, Andersson M, Bastholt L, Møller KA, Andersen J, Munkholm P, Dombernowsky P, Christensen IJ. Rose C, et al. Among authors: mouridsen ht. Breast Cancer Res Treat. 2000 May;61(2):103-10. doi: 10.1023/a:1006460925986. Breast Cancer Res Treat. 2000. PMID: 10942095 Clinical Trial.
397 results